{"disease":{"id":"drug-withdrawal","name":"drug withdrawal"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03909191","title":"Serum HBV RNA Value on Chronic Hepatitis B Virus Infection Manage","phase":"","overall_status":"COMPLETED","enrollment_count":454,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT05461820","title":"Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT03918850","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT04320381","title":"Qualitative Understanding of Experiences With the SIMPLIFY Trial","phase":"","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT03911466","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study","phase":"","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT03911739","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study","phase":"","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT06029634","title":"Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT05746507","title":"Night Respite for Postpartum Mothers With SUD","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04939623","title":"Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT03489161","title":"Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Virginia Commonwealth University","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}